期刊文献+

血清中丙型肝炎NS3抗原ELISA检测方法的建立和初步应用 被引量:2

The clinical application and analysis of hepatitis C virus NS3 antigen detection by ELISA in human serum
原文传递
导出
摘要 目的评价血清中丙型肝炎病毒(HCV)游离Ns,抗原的酶联免疫吸附(ELISA)检测方法的特异性和灵敏度,初步探讨该方法在临床应用中的意义。方法对77例正常人血清标本,173例抗-HCV阳性标本和3708例抗-HCV阴性的其他类型肝炎血清标本检测HCV游离NS,抗原;对部分HCVNS,抗原阳性标本进行验证,包括HCVRNA测定、中和试验和免疫斑点试验;对11例患者的25份系列血清标本进行rHCV游离Ns,抗原、HCVRNA和HCV抗体的联合检测,并结合临床资料综合分析。结果3708例抗-HCV阴性的其他类型肝炎血清标本中有48例为HCVNS,抗原阳性,其中3030例单纯乙型肝炎和445例其他类型肝炎血清标本中分别有44例和4例为HCVNS,抗原阳性;173例HCV抗体阳性标本中有42例为HCVNS,抗原阳性;77例正常人血清标本的HCVNS,抗原检测结果均为阴性;15例HCVNS,抗原阳性标本中有9例为HCVRNA阳性;23例HCVNS,抗原阳性标本的中和率和免疫斑点试验的阳性率分别为87.0%和69.6%;25份系列血清标本的检测结果显示其HCVNS,抗原的吸光度值与时间呈负相关,并有2例HCVNS,抗原阳性标本随着血清中HCVNS,抗原的吸光度值下降,其HCV抗体转阳。结论血清中HCV游离NS,抗原的ELISA检测方法有较好的特异性和敏感度,在发展中国家应用此方法进行HCV感染的早期诊断有-定的临床意义和推广价值。 Objective To evaluate the specificity and sensitivity of a novel hepatitis C virus NS3 antigen detection immunoassay and the potential application of this assay in clinical diagnosis. Methods Samples from 77 healthy subjects, 173 anti-HCV-positive patients and 3708 patients infected with other type of hepatitis were tested with the HCV NS3 antigen assay, some HCV NS3 antigen positive samples were vali- dated with HCV-RNA, neutralization and immunodot assays. Twenty-five sequential samples from 11 HCV NS3 antigen positive patients were subjected to kinetic study. Results Forty-eight ( 1.3% ) of 3708 anti- HCV negative samples were positive for HCV NS3 antigen. Among them, 44 of 3030 samples from patients only infected with HBV were HCV NS3 antigen-positive, 4 of the 445 samples from patients infected with other type hepatitis were HCV NS3 antigen-positive. In addition, 42 (24.3%) of 173 anti-HCV positive sam- ples were HCV NS3 antigen-positive and all 77 samples from healthy subjects were negative to HCV NS3 anti- gen assay. Of 15 HCV NS3 antigen-positive samples, 9 (60%) were HCV-RNA positive. The neutralization and positive percentage of immunodot assay for 23 HCV NS3 antigen-positive sera were 87.0% (20/23) and 69.6% (16/23) respectively. Of the 25 sequential samples from 11 HCV NS3 antigen positive patients, there was a negative correlation between the A values and the duration of test, and there were correlations among their HCV NS3 antigen, HCV-RNA and anti-HCV; In addition, the anti-HCV antibodies of two sera were detected while their A values of HCV NS3 antigen decreased gradually. Conclusion The HCV NS3 antigen detection assay showed perfect specificity and higher sensitivity, it will be useful in routine laboratories test in developing countries for earlier diagnosis of HCV infection.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第1期88-92,共5页 Chinese Journal of Microbiology and Immunology
基金 基金项目:首都医学发展科研基金课题(2002-3068) 首都医科大学基础临床合作基金课题(02JL20)
关键词 丙型肝炎病毒 丙型肝炎病毒Ns 抗原 丙型肝炎病毒RNA 丙型肝炎病毒抗体 酶联免疫吸附试验 Hepatitis C virus(HCV) HCV NS3 antigen HCV RNA HCV antibody ELISA
  • 相关文献

参考文献25

  • 1邢文革,郑怀竞.必须提高丙型肝炎病毒实验室检验结果的可信度[J].中华肝脏病杂志,2004,12(3):170-171. 被引量:55
  • 2Levine CD, Ghalib RH. Assessment of the patient who failed treatment for chronic hepatitis C. Gastroenterol Nurs, 2005, 28 (3 Suppl) : S24-S30.
  • 3庄辉.关注我国第一部《丙型肝炎防治指南》[J].中华肝脏病杂志,2004,12(4):193-193. 被引量:8
  • 4Re V, Gallego S, Trevino E, et al. Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies. Mere Inst Oswaldo Cruz, 2005, 100(3) : 303-307.
  • 5Fabrizi F, Lunghi G, Aucella F, et al. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol, 2005, 43 ( 1 ) : 414-420.
  • 6Tobler LH, Stramer SL, Lee SR, et al. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors. Vox Sang, 2005, 89(4) : 201-207.
  • 7谢立,黄德庄,时洪波,贺丽香,靳海英.用酶联免疫夹心法测定肝炎患者血清丙型肝炎抗原[J].中华检验医学杂志,2005,28(11):1159-1162. 被引量:15
  • 8谢立,陈万荣,张明程,黄德庄,贺立香.丙型肝炎病毒单克隆抗体的制备及其鉴定[J].天津医药,2005,33(8):508-510. 被引量:3
  • 9Tanaka E, Ohue C, Aoyagi K, et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology, 2000, 32(2) : 388-393.
  • 10Widell A, Molnegren V, Pieksma F, et al. Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase. Transfusion Med, 2002, 12 (2) : 107-113.

二级参考文献31

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2任芙蓉,庄辉.丙型肝炎病毒抗体酶联免疫试验S/CO比值与补充试验阳性的相关性研究进展[J].中华检验医学杂志,2005,28(10):1096-1099. 被引量:17
  • 3郝飞,李梦东,M.Michael Thaler,陈国致.不同人群血清单项丙型肝炎病毒核心抗体存在状态[J].中华传染病杂志,1996,14(3):141-143. 被引量:10
  • 4Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 5Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 6Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 7Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 8Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 9Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 10Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.

共引文献872

同被引文献53

  • 1谢立,陈万荣,张明程,黄德庄,贺立香.丙型肝炎病毒单克隆抗体的制备及其鉴定[J].天津医药,2005,33(8):508-510. 被引量:3
  • 2费嘉,马文丽,吴清华,郑文岭.介质表面修饰对蛋白质芯片固定率和反应性的影响[J].生命科学研究,2005,9(4):341-345. 被引量:5
  • 3Laperche S, Le Marrec N, Simon N, et al. A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection. Transfusion, 2003, 43(7): 958-962.
  • 4Guilleaume B, Buness A, Schmidt C, et al. Systematic comparison of surface coatings for protein microarrays. Proteomics, 2005, 5(18): 4705-4712.
  • 5Panicker RC, Huang X, Yao SQ. Recent advances in peptide-based microarray technologies. Comb Chem High Throughput Screen, 2004, 7(6): 547-556.
  • 6Kusnezow W, Hoheisel JD. Solid supports for microarray immunoassays. JMol Recognit, 2003, 16(4): 165-176.
  • 7Wilson DS, Nock S. Functional protein microarrays. Curr Opin Chem Biol, 2002, 6(1): 81-85.
  • 8Kusnezow W, Jacob A, Walijew A, et al. Antibody microarrays: an evaluation of production parameters. Proteomics, 2003, 3(3): 254-264.
  • 9Shepard C W,Finelli L,Alter M et al.Global epidemiology ofhepatitis C virus infection[J].Lancet Infect Dis,2005,5:558-567.
  • 10Racanelli V,Frassanito M A,Leone P,et al.Antibody pro-duction and in vitro behavior of CD27-defined B-cell subsets:persistent hepatitis C virus infection changes the rules[J].JVirol,2006,8:3923-3934.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部